Fagron NV signed an agreement to acquire Parma Produkt Gyógyszergyártó Korlátolt Felelosségu Társaság.
close early January 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.24 EUR | -0.22% | +2.70% | +9.81% |
Apr. 11 | Transcript : Fagron NV, Q1 2024 Sales/ Trading Statement Call, Apr 11, 2024 | |
Apr. 11 | Fagron Reports Revenue Results for the First Quarter Ended 31 March 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
+9.81% | 1.43B | |
+26.08% | 662B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
-3.40% | 157B |